PERIPHERAL BLOOD MONONUCLEAR DNA DAMAGE IDENTIFIED BY THE «СOMET» METHOD, AS A POSSIBLE INDICATOR OF SENSITIVITY OF MELANOMA TO IMMUNOTHERAPY WITH NIVOLUMAB

by E. V. Tsyrlina, T. E. Poroshina, A. P. Oganesyan, S. A. Protsenko, L. M. Bershtein
Published 2021-05-01

Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya

by V F Semiglazov, V V Semiglazov, V G Ivanov, L M Bershteyn, E V Tsyrlina, E K Zhil'tsova, A S Arzumanov, K Sh Nurgaziev
Published 2001-03-01

ANALYSIS OF A MIRNA SET (MIR-21, -181A, AND -146A) AS A METHOD OF DIFFERENTIAL DIAGNOSIS OF THYROID NODULES

by R. B. Samsonov, V. S. Burdakov, T. A. Shtam, Z. A. Radzhabova, Y. V. Cheburkin, D. A. Vasilyev, E. V. Tsyrlina, S. E. Titov, M. К. Ivanov, M. V. Filatov, L. M. Berstein, N. N. Kolesnikov, А. V. Malek
Published 2017-06-01

Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy

by V F Semiglazov, E K Zhil'tsova, V V Semiglazov, V G Ivanov, G A Dashyan, A A Klettsel', A A Bozhok, K S Nurgaziev, E E Topuzov, P V Krivorot'ko, E V Tsyrlina, L M Bershteyn
Published 2003-12-01

Diagnostic score of malignancy risk in the people having a node in thyroid gland (Petrov Thyroid Cancer Score, PTCS)

by A. M. Belyaev, L. M. Berstein, D. A. Vasil’ev, E. V. Kostromina, L. A. Krasil’nikova, P. I. Krzhivitskiy, A. A. Mikhet’ko, A. V. Mishchenko, S. N. Novikov, Z. A. Radzhabova, D. A. Sinyachkina, E. V. Tsyrlina
Published 2018-04-01